You are here

cancer

AstraZeneca signs Alteogen deal worth up to $1.35B for subcutaneous cancer drugs despite Merck-Halozyme patent drama

Fierce Pharma

Mon, 03/17/25 - 10:11 pm

subcutaneous drug delivery

Labcorp is buying Bioreference health’s cancer testing business for $192m

MedCity News

Sun, 03/16/25 - 09:52 pm

BioReference Labs

This Could Be the Catalyst That Sends Summit Therapeutics' Stock Higher This Year

Motley Fool

Thu, 03/13/25 - 11:32 am

Summit Therapeutics

non-small cell lung cancer

Everest Medicines begins dosing in mRNA cancer vaccine trial

Clinical Trials Arena

Fri, 03/7/25 - 11:02 am

Everest Medicines

cancer vaccines

clinical trials

Moderna Eyes 2027 Launch for Cancer Vaccine Developed With Merck

MSN/Bloomberg

Wed, 03/5/25 - 11:26 pm

Moderna Therapeutics

clinical trials

Where Will Eli Lilly Be in 5 Years?

Motley Fool

Sun, 03/2/25 - 09:41 pm

ulcerative colitis

NeOnc: bypassing the blood-brain barrier in brain cancer

Clinical Trials Arena

Fri, 02/28/25 - 11:15 am

internasal drug delivery

blood-brain barrier

Perlmutter's Eikon raises $351m in major financing round

Pharmaphorum

Wed, 02/26/25 - 09:58 am

Eikon Therapeutics

Roger Perlmutter

VA and HHS Object to Johnson & Johnson Talc Cancer Plan

Mesothelioma Guide

Sun, 02/16/25 - 07:40 pm

Otsuka breaks up with cancer candidates on strategic grounds

Fierce Biotech

Fri, 02/14/25 - 09:22 am

Amgen ends Ideaya cancer combination trial after partner unveils rival molecule

Fierce Biotech

Thu, 02/13/25 - 09:45 pm

IDEAYA Biosciences

AdvanCell, Lilly partner on new targeted alpha therapies for cancer treatment

Pharmaceutical Business Review

Tue, 02/11/25 - 11:27 am

radiopharmaceuticals

alpha radiation

Pfizer taps a former Novartis exec to lead cancer drug push

BioPharma Dive

Thu, 02/6/25 - 11:38 am

Ascentage raises $126m in first biotech IPO of 2025

Pharmaphorum

Mon, 01/27/25 - 11:15 am

Ascentage Pharma

Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.

Motley Fool

Sun, 01/26/25 - 04:13 pm

The FDA pulls key DEI initiative for cancer studies from its website

NPR

Sun, 01/26/25 - 04:06 pm

clinical trial diversity

clinical trials

Trump Administration Delays Funding To Cancer Research

Forbes

Thu, 01/23/25 - 11:13 pm

clinical trials

FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain

MSN/Reuters

Tue, 01/14/25 - 06:08 pm

Express Scripts

JPM25: Strategist GSK acquires IDRx for $1B in hopes of bringing GIST patients new standard of care

Fierce Biotech

Mon, 01/13/25 - 11:18 am

precision medicine

Lilly pads cancer drug pipeline with Scorpion deal

BioPharma Dive

Mon, 01/13/25 - 11:00 am

Scorpion Therapeutics

Pages